Breakout Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)Brad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersGlobal BioAccess FundNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)
Co-investorsAccelr8Breakout LabsCavallo VenturesDudley FundFreshTracks CapitalPrime Partners+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.